WTO's COVID deal: more vaccine ‘enabler’ than IP waiver?

After several days and sleepless nights, members of the World Trade Organisation (WTO) finally agreed several key trade initiatives last week, including one that promises to suspend patent protection of the COVID-19 vaccines.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Europe

EU court under pressure to define SPC limits in patent row

24 April 2026 An opinion has put pressure on the CJEU to clarify a long-running grey area that could change the game for how drug makers secure supplementary protection certificates across Europe.

Americas

Amneal acquires biopharma ahead of $300bn patent wave

23 April 2026 The US pharma giant is spending up to $1 billion to build an end-to-end biosimilar platform and is counting on a decade of expiring biologic patents to make it pay off.

Americas

Health tech firm sues Nvidia-backed rival over ‘brazen’ theft

23 April 2026 Plaintiff alleges that a $6 billion rival probed its records system via a long-term customer, using confidential information to develop its product in the behavioural health tech space.

More features

Patent office fee increases: What applicants must know

IndiaMart v CDSCO: A test of intermediary liability

mRNA litigation: Who’s winning, who’s filing, and what’s next

Moderna inks billion-dollar deal to settle long-running Spikevax dispute

Emotional Perception: What next for patent holders?

BioNTech fires shots at Moderna's next-generation vaccine

Moderna VP and regulatory expert moves to private practice

Rooted in rights: Lessons from plant patent infringement and invalidity cases

WTO's COVID deal: more vaccine ‘enabler’ than IP waiver?

More on this story

Editor's picks

Editor's picks

More features